Lia Tesfay

3.1k total citations · 1 hit paper
22 papers, 2.0k citations indexed

About

Lia Tesfay is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Lia Tesfay has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Lia Tesfay's work include Iron Metabolism and Disorders (9 papers), Hemoglobinopathies and Related Disorders (7 papers) and Trace Elements in Health (6 papers). Lia Tesfay is often cited by papers focused on Iron Metabolism and Disorders (9 papers), Hemoglobinopathies and Related Disorders (7 papers) and Trace Elements in Health (6 papers). Lia Tesfay collaborates with scholars based in United States, South Korea and Germany. Lia Tesfay's co-authors include Suzy V. Torti, Frank M. Torti, Lance D. Miller, Heather Hatcher, Ralph B. D’Agostino, Mark C. Willingham, Ian Pass, Sara A. Courtneidge, Darren F. Seals and Guangchao Sui and has published in prestigious journals such as PLoS ONE, Cancer Cell and Cancer Research.

In The Last Decade

Lia Tesfay

22 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron addiction: a novel therapeutic target in ovarian cancer

2017 355 citations Debargha Basuli, Lia Tesfay et al. Oncogene profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lia Tesfay United States	15	920	638	512	497	375	22	2.0k
Fernando Doñate United States	22	897 1.0×	162 0.3×	145 0.3×	341 0.7×	146 0.4×	56	1.8k
Yong Xu China	26	1.1k 1.2×	158 0.2×	404 0.8×	631 1.3×	69 0.2×	83	2.1k
Steven Pirie‐Shepherd United States	19	815 0.9×	138 0.2×	148 0.3×	398 0.8×	88 0.2×	36	1.4k
Christine Fritsch Switzerland	21	1.8k 2.0×	129 0.2×	401 0.8×	258 0.5×	49 0.1×	39	2.6k
William Senapedis United States	29	1.6k 1.8×	366 0.6×	193 0.4×	202 0.4×	37 0.1×	79	2.1k
Charlotte Kopitz Germany	19	981 1.1×	122 0.2×	361 0.7×	787 1.6×	30 0.1×	40	1.7k
Christos K. Kontos Greece	31	1.7k 1.8×	220 0.3×	202 0.4×	1.2k 2.4×	23 0.1×	122	2.7k
Alessandra Boe Italy	21	693 0.8×	114 0.2×	87 0.2×	412 0.8×	52 0.1×	37	1.2k
Merav Darash‐Yahana Israel	17	573 0.6×	153 0.2×	199 0.4×	160 0.3×	56 0.1×	20	1.4k
Erwin R. Boghaert United States	26	1.2k 1.3×	370 0.6×	170 0.3×	196 0.4×	15 0.0×	58	2.5k

Countries citing papers authored by Lia Tesfay

Since Specialization

Citations

This map shows the geographic impact of Lia Tesfay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lia Tesfay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lia Tesfay more than expected).

Fields of papers citing papers by Lia Tesfay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lia Tesfay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lia Tesfay. The network helps show where Lia Tesfay may publish in the future.

Co-authorship network of co-authors of Lia Tesfay

This figure shows the co-authorship network connecting the top 25 collaborators of Lia Tesfay. A scholar is included among the top collaborators of Lia Tesfay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lia Tesfay. Lia Tesfay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Torti, Suzy V., Lia Tesfay, & Frank M. Torti. (2025). Iron and Cancer. Advances in experimental medicine and biology. 1480. 271–289. 1 indexed citations

Taylor, Michael J., Lia Tesfay, Jessica Lukowski, et al.. (2023). Applying Multimodal Mass Spectrometry to Image Tumors Undergoing Ferroptosis Following In Vivo Treatment with a Ferroptosis Inducer. Journal of the American Society for Mass Spectrometry. 35(1). 5–12. 9 indexed citations

Tesfay, Lia, Bibbin T. Paul, Poornima Hegde, et al.. (2022). Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer. Scientific Reports. 12(1). 19936–19936. 6 indexed citations

Torti, Suzy V., Lia Tesfay, Frank M. Torti, et al.. (2021). 38 Daily vs. Intermittent Iron Therapy in Moderate Iron Deficient Pregnant Patients: A Randomized Non-inferiority Trial. American Journal of Obstetrics and Gynecology. 224(2). S28–S28. 2 indexed citations

Konstorum, Anna, Lia Tesfay, Bibbin T. Paul, et al.. (2020). Systems biology of ferroptosis: A modeling approach. Journal of Theoretical Biology. 493. 110222–110222. 36 indexed citations

Paul, Bibbin T., Lia Tesfay, Christopher Winkler, Frank M. Torti, & Suzy V. Torti. (2019). Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes. Scientific Reports. 9(1). 19634–19634. 35 indexed citations

Moghieb, Ahmed, Lia Tesfay, Song Nie, et al.. (2019). A Targeted Mass Spectrometric Assay for Reliable Sensitive Hepcidin Quantification. Scientific Reports. 9(1). 7264–7264. 6 indexed citations

Kita, Daniel, Anna Konstorum, Lia Tesfay, et al.. (2018). Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer. Oncogene. 37(29). 4013–4032. 45 indexed citations

Lynch, Miranda L., Lia Tesfay, Zhiyong Deng, et al.. (2017). DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms. Breast Cancer Research. 19(1). 25–25. 30 indexed citations

10.

Basuli, Debargha, Lia Tesfay, Zhao Deng, et al.. (2017). Iron addiction: a novel therapeutic target in ovarian cancer. Oncogene. 36(29). 4089–4099. 355 indexed citations breakdown →

11.

Tesfay, Lia, et al.. (2016). Receptor tyrosine kinase Met promotes cell survival via kinase-independent maintenance of integrin α3β1. Molecular Biology of the Cell. 27(15). 2493–2504. 11 indexed citations

12.

Blanchette, Nicole, Lia Tesfay, Daniel Kita, et al.. (2016). A Novel Role for the Extracellular Matrix in Regulation of Hepcidin in Breast Cancer Spheroids. The FASEB Journal. 30(S1). 1 indexed citations

13.

Tesfay, Lia, Jin Woo Kim, Poornima Hegde, et al.. (2015). Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer. Cancer Research. 75(11). 2254–2263. 139 indexed citations

14.

Hatcher, Heather, Lia Tesfay, Suzy V. Torti, & Frank M. Torti. (2015). Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury. PLoS ONE. 10(9). e0138505–e0138505. 26 indexed citations

15.

Wang, Wei, Zhiyong Deng, Heather Hatcher, et al.. (2013). IRP2 Regulates Breast Tumor Growth. Cancer Research. 74(2). 497–507. 117 indexed citations

16.

Tesfay, Lia, et al.. (2012). Ferritin Blocks Inhibitory Effects of Two-Chain High Molecular Weight Kininogen (HKa) on Adhesion and Survival Signaling in Endothelial Cells. PLoS ONE. 7(7). e40030–e40030. 29 indexed citations

17.

Miller, Lance D., Wei Wang, Ralph B. D’Agostino, et al.. (2010). Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis. Science Translational Medicine. 2(43). 43ra56–43ra56. 324 indexed citations

18.

Edick, Mathew J., Lia Tesfay, Laura E. Lamb, Beatrice S. Knudsen, & Cindy K. Miranti. (2007). Inhibition of Integrin-mediated Crosstalk with Epidermal Growth Factor Receptor/Erk or Src Signaling Pathways in Autophagic Prostate Epithelial Cells Induces Caspase-independent Death. Molecular Biology of the Cell. 18(7). 2481–2490. 61 indexed citations

19.

Courtneidge, Sara A., et al.. (2005). The Src Substrate Tks5, Podosomes (Invadopodia), and Cancer Cell Invasion. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 167–171. 74 indexed citations

20.

Seals, Darren F., Ian Pass, Lia Tesfay, et al.. (2005). The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell. 7(2). 155–165. 298 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact